LabCompass

Priyanka Mehta

Medicine · The Ohio State University

Established · publishing since 1982

Publications

111

Citations

1,947

Est. group size

~3

Recurring co-author estimate

Active years

45

Publishing since 1982

Research summary
AI-generated

Priyanka Mehta's research focuses on acute myeloid leukemia (AML) and related blood cancers, particularly evaluating treatment regimens such as CPX-351, venetoclax combinations, and gemtuzumab ozogamicin through large UK clinical trials (e.g., NCRI AML17, AML18, AML19). This work examines how patient fitness, genetic mutations (like NPM1 and FLT3), and measurable residual disease affect treatment choice and outcomes, especially in older or higher-risk patients. A prospective student would engage with clinical trial data analysis, real-world treatment outcomes research, and consensus-building efforts to improve AML care pathways.

Acute myeloid leukemia treatment and clinical trialsMeasurable residual disease and risk stratificationReal-world outcomes research in hematologyElderly and high-risk patient care in leukemiaSleep disorders and comorbidities (recent adjacent work)

Publication output has grown substantially over the past decade, rising from around 4 papers per year in 2017 to a peak of 17 in 2022-2023, with continued strong activity averaging over 11 papers per year in the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 11.2/year recently
2017: 4 publications172018: 7 publications182019: 8 publications192020: 7 publications202021: 10 publications212022: 17 publications17222023: 17 publications17232024: 6 publications242025: 10 publications252026: 6 publications26
Recent publications
Publishes in
  • Blood×24
  • British Journal of Haematology×7
  • HemaSphere×6
  • Blood Advances×4
  • Clinical Lymphoma Myeloma & Leukemia×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile